Fresenius SE & Co KGaA (FSNUY)
7.40
+0.10
(+1.37%)
USD |
OTCM |
Apr 22, 16:00
Fresenius Cash from Financing (TTM): -1.491B for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -1.491B |
September 30, 2023 | -2.017B |
June 30, 2023 | -1.798B |
March 31, 2023 | -1.438B |
December 31, 2022 | -1.692B |
September 30, 2022 | -1.838B |
June 30, 2022 | -2.034B |
March 31, 2022 | -1.917B |
December 31, 2021 | -1.718B |
September 30, 2021 | -2.290B |
June 30, 2021 | -2.748B |
March 31, 2021 | -3.797B |
December 31, 2020 | -3.560B |
September 30, 2020 | -2.396B |
June 30, 2020 | -2.079B |
March 31, 2020 | -1.514B |
December 31, 2019 | -541.84M |
September 30, 2019 | -566.56M |
June 30, 2019 | 177.55M |
March 31, 2019 | -772.80M |
December 31, 2018 | -1.503B |
September 30, 2018 | -2.156B |
June 30, 2018 | -2.169B |
March 31, 2018 | -918.92M |
December 31, 2017 | 4.385B |
Date | Value |
---|---|
September 30, 2017 | 4.912B |
June 30, 2017 | 4.497B |
March 31, 2017 | 4.431B |
December 31, 2016 | -1.078B |
September 30, 2016 | -1.530B |
June 30, 2016 | -1.546B |
March 31, 2016 | -1.513B |
December 31, 2015 | -2.199B |
September 30, 2015 | -1.150B |
June 30, 2015 | -1.025B |
March 31, 2015 | -545.86M |
December 31, 2014 | 1.387B |
September 30, 2014 | 3.540B |
June 30, 2014 | 3.876B |
March 31, 2014 | 3.464B |
December 31, 2013 | 1.733B |
September 30, 2013 | -1.347B |
June 30, 2013 | -2.071B |
March 31, 2013 | -760.64M |
December 31, 2012 | 1.382B |
September 30, 2012 | 2.137B |
June 30, 2012 | 2.527B |
March 31, 2012 | 1.691B |
December 31, 2011 | 337.43M |
September 30, 2011 | 100.37M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-3.797B
Minimum
Mar 2021
177.55M
Maximum
Jun 2019
-1.856B
Average
-1.838B
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Fresenius Medical Care AG | -2.012B |
Affimed NV | -6.734M |
InflaRx NV | 57.36M |
MorphoSys AG | -- |
BioNTech SE | -842.92M |